These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3234203)

  • 1. [Estimating the optimum dose of antineoplastic agents based on the level of DNA damage in human blood leukocytes in vitro].
    Fedorov NA; Diachenko LV
    Dokl Akad Nauk SSSR; 1988; 302(5):1233-5. PubMed ID: 3234203
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA-protein crosslinks induced in HeLa cells by bis-1-nitroacridines.
    Pastwa E; Ciesielska E; Studzian K; Szmigiero L
    Acta Biochim Pol; 1993; 40(1):69-71. PubMed ID: 8372570
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor efficacy and molecular mechanism of TLK58747, a novel DNA-alkylating prodrug.
    Xu H; Wang Z; Donaldson JC; Yao H; Zhou S; Kelson AB; Ma W; Weber KT; Laborde E; Cheng M; Sambucetti L; Keck JG
    Anticancer Res; 2009 Oct; 29(10):3845-55. PubMed ID: 19846918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of ribo-and arabinoside boron nucleosides in tissue culture cells.
    Sood A; Spielvogel BF; Powell WJ; Bastow KF; Miller MC; Hall IH
    Anticancer Res; 1994; 14(4A):1483-8. PubMed ID: 7979174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro.
    Oshita F; Yamamoto N; Fukuda M; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
    Cancer Res; 1995 Jun; 55(11):2334-7. PubMed ID: 7757984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic role of determining spontaneous leukocyte DNA damage and that occurring during chemotherapy in leukemia patients].
    Morozova EO; Sidorova ZhIu; Blinov MN; Moiseev SI; Samuskevich IG; Shcherbakova EG; Abdulkadyrov KM
    Vestn Ross Akad Med Nauk; 1993; (4):20-5. PubMed ID: 7687479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
    Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
    Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Design of a new antitumor nucleoside CNDAC, against solid tumors].
    Matsuda A
    Gan To Kagaku Ryoho; 1996 Jan; 23(2):202-10. PubMed ID: 8611048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
    Kataoka S; Naito M; Tomida A; Tsuruo T
    Exp Cell Res; 1994 Nov; 215(1):199-205. PubMed ID: 7957669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY; Ali-Osman F
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of tributyltin(IV) chloride and a related complex [Bu(3)Sn(LSM)] with rat leukocytes and erythrocytes: Effect on DNA and on plasma membrane.
    Falcioni ML; Pellei M; Gabbianelli R
    Mutat Res; 2008 May; 653(1-2):57-62. PubMed ID: 18487081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of topoisomerase I/DNA complexes in patients administered topotecan.
    Subramanian D; Kraut E; Staubus A; Young DC; Muller MT
    Cancer Res; 1995 May; 55(10):2097-103. PubMed ID: 7743509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
    Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
    Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Antitumor efficacy testing in rodents.
    Poggesi I; de Nicolao G; Germani M; Rocchetti M
    J Natl Cancer Inst; 2009 Nov; 101(22):1592-3; author reply 1593-4. PubMed ID: 19864637
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of sequence-specific antitumor alkylating agent DNA damage from cells treated in culture and from a patient.
    Bubley GJ; Ogata GK; Dupuis NP; Teicher BA
    Cancer Res; 1994 Dec; 54(24):6325-9. PubMed ID: 7987822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
    Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
    Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays.
    Pawlik CA; Houghton PJ; Stewart CF; Cheshire PJ; Richmond LB; Danks MK
    Clin Cancer Res; 1998 Aug; 4(8):1995-2002. PubMed ID: 9717830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [JM216, an orally active platine derivative].
    Lansiaux A; Bailly C
    Bull Cancer; 2000 Jul; 87(7-8):531-6. PubMed ID: 10969209
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
    Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
    Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.